Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
2,950.94
2,622.85
2,177.41
1,852.14
1,490.84
1,376.18
1,134.21
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,950.94
2,622.85
2,177.41
1,852.14
1,490.84
1,376.18
1,134.21
Raw Material Cost
959.21
753.02
667.70
612.97
540.67
419.76
371.33
Purchase of Finished goods
454.49
574.48
444.28
314.78
163.25
311.57
120.60
(Increase) / Decrease In Stocks
-136.42
-183.76
-73.86
-6.39
12.90
-136.28
52.95
Employee Cost
420.93
350.30
293.64
239.37
220.30
197.32
168.42
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
651.95
596.12
387.07
352.09
294.84
244.20
228.66
Total Expenditure (Excl Depreciation)
2,350.16
2,090.16
1,718.83
1,512.82
1,231.96
1,036.58
941.96
Operating Profit (PBDIT) excl Other Income
600.78
532.69
458.58
339.32
258.88
339.60
192.25
Other Income
82.53
66.33
50.42
59.31
41.85
6.69
0.33
Operating Profit (PBDIT)
683.31
599.02
509.00
398.63
300.73
346.29
192.58
Interest
24.13
11.66
11.20
9.13
8.45
7.99
8.75
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
659.18
587.36
497.80
389.50
292.28
338.30
183.83
Depreciation
98.63
83.39
74.27
51.85
44.78
36.15
26.66
Profit Before Tax
560.56
503.97
423.53
337.65
247.51
302.16
157.17
Tax
140.49
121.35
108.63
72.33
60.70
63.63
36.42
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
420.06
382.62
314.90
265.32
186.81
238.54
120.75
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
420.06
382.62
314.90
265.32
186.81
238.54
120.75
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-2.16
-2.04
-1.20
0.99
-2.25
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
417.90
380.58
313.70
266.31
184.57
238.54
120.75
Equity Capital
45.32
45.32
45.32
45.32
40.93
40.93
40.93
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,977.84
2,421.60
2,019.74
1,699.85
1,161.34
845.56
595.08
Earnings per share (EPS)
9.22
8.4
6.92
5.88
4.51
5.83
2.95
Diluted Earnings per share
9.22
8.4
6.92
6.41
4.51
5.76
2.86
Operating Profit Margin (Excl OI)
20.36%
20.31%
21.06%
18.32%
17.36%
24.68%
16.95%
Gross Profit Margin
22.34%
22.39%
22.86%
21.03%
19.61%
24.58%
16.21%
PAT Margin
14.23%
14.59%
14.46%
14.33%
12.53%
17.33%
10.65%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 12.51% vs 20.46% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 9.81% vs 21.32% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 12.78% vs 16.16% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 106.95% vs 4.11% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Marksans Pharma With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
2,950.94
0
2,950.94
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,950.94
0
2,950.94
Raw Material Cost
959.21
0
959.21
Purchase of Finished goods
454.49
0
454.49
(Increase) / Decrease In Stocks
-136.42
0
-136.42
Employee Cost
420.93
0
420.93
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
651.95
0.00
651.95
Total Expenditure (Excl Depreciation)
2,350.16
0
2,350.16
Operating Profit (PBDIT) excl Other Income
600.78
0.00
600.78
Other Income
82.53
0
82.53
Operating Profit (PBDIT)
683.31
0
683.31
Interest
24.13
0
24.13
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
659.18
0
659.18
Depreciation
98.63
0
98.63
Profit Before Tax
560.56
0
560.56
Tax
140.49
0
140.49
Provisions and contingencies
0.00
0
0.00
Profit After Tax
420.06
0
420.06
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
420.06
0
420.06
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-2.16
0
-2.16
Other related items
0.00
0.00
0.00
Consolidated Net Profit
417.90
0
417.90
Equity Capital
45.32
0
45.32
Face Value
1.00
0
0.00
Reserves
2,977.84
0
2,977.84
Earnings per share (EPS)
9.22
0
9.22
Diluted Earnings per share
9.22
0
9.22
Operating Profit Margin (Excl OI)
20.36%
0%
0.00
20.36%
Gross Profit Margin
22.34%
0%
0.00
22.34%
PAT Margin
14.23%
0%
0.00
14.23%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 2,950.94 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 12.51% vs 20.46% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 417.90 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 9.81% vs 21.32% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 600.78 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 12.78% vs 16.16% in Mar 2025
Annual - Interest
Interest 24.13 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 106.95% vs 4.11% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.36%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
